Acorn Capital Advisors, Llc Portfolio Stock Holdings

Acorn Capital Advisors, Llc disclosed 22 stock positions valued at approximately $351.8 million in its latest SEC 13F filing. The largest holdings include TERNS PHARMACEUTICALS INC, CG ONCOLOGY INC, and PUMA BIOTECHNOLOGY INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
22
Portfolio Value
$351.8M
Holdings by Sector
Acorn Capital Advisors, Llc Portfolio Holdings in Q1 2026

15 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
TERNS PHARMACEUTICALS INCTERNHealthcare26.17%1,746,264--$92,063,038
CG ONCOLOGY INCCGONHealthcare21.77%1,130,501-1,000-0.09%$76,579,958
PUMA BIOTECHNOLOGY INCPBYIHealthcare7.50%4,131,299--$26,399,001
TREVI THERAPEUTICS INCTRVIHealthcare7.27%2,144,844--$25,587,989
CANDEL THERAPEUTICS INCCADLHealthcare4.89%3,497,948+917,431+35.55%$17,209,904
PROTARA THERAPEUTICS INCTARAHealthcare2.59%1,752,115--$9,128,519
VERASTEM INCVSTMHealthcare2.21%1,469,153--$7,786,511
AURA BIOSCIENCES INCAURAHealthcare1.13%595,744--$3,985,527
WHITEHAWK THERAPEUTICS INCAADIHealthcare1.12%1,139,363--$3,930,802
CARDIF ONCOLOGY INCCRDFHealthcare0.81%1,762,084-200,000-10.19%$2,854,576
Q32 BIO INC.QTTBHealthcare0.57%315,052-178,373-36.15%$2,022,634
JASPER THERAPEUTICSJSPRHealthcare0.35%1,411,492-375,000-20.99%$1,242,113
X4 PHARMACEUTICALS INCXFORHealthcare0.27%234,039-39,310-14.38%$966,583
BIOATLA INCBCABHealthcare0.25%5,406,345+571,234+11.81%$865,015
VYNE THERAPEUTICS INCVYNEHealthcare0.00%1,425--$855